Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Ginkgo Bioworks Holdings Inc. (DNA)

  • Business News
  • Sept. 04, 2025, 12:00 UTC
  • 7
  • 0 comments

Ginkgo Datapoints and Apheris Launch Antibody Developability Consortium

Market reaction Comment Full text

Science 37 Holdings Inc (was acquired by eMed, LLC (“eMed”) on 29/01/2024) (SNCE)

  • Business News
  • Sept. 04, 2025, 12:00 UTC
  • 8
  • 0 comments

Science 37 and Catalent Announce Partnership Enabling Universal Access to Clinical Research

Market reaction Comment Full text

Cidara Therapeutics Inc. (CDTX)

  • Business News
  • Sept. 04, 2025, 11:59 UTC
  • 9
  • 0 comments

Cidara Therapeutics to Participate in September Investor Conferences

Market reaction Comment Full text

United Therapeutics Corporation (UTHR)

  • Business News
  • Sept. 04, 2025, 11:58 UTC
  • 8
  • 0 comments

UTHR: Notification

Market reaction Comment Full text

United Therapeutics Corporation (UTHR)

  • SEC News
  • Sept. 04, 2025, 11:53 UTC
  • 7
  • 1 comments

BENKOWITZ MICHAEL 🟡 adjusted position in 22.5K shares (2 derivative) of UNITED THERAPEUTICS Corp (UTHR) at $419.63 ($15.7M) Transaction Date: Sep 02, 2025 | Filing ID: 000002

Comment Full text

HEALTHY EXTRACTS INC. (HYEX)

  • Business News
  • Sept. 04, 2025, 11:52 UTC
  • 9
  • 0 comments

Healthy Extracts Builds Upon Record Q2 Results and Transformative Merger with Launch of New Revolutionary Hydration and Sugar Metabolism Gel-Packs

Market reaction Comment Full text

Avita Medical Ltd (RCEL)

  • Business News
  • Sept. 04, 2025, 11:45 UTC
  • 11
  • 0 comments

Real-World Data Shows Significant Reduction in Hospital Stay Using AVITA Medical’s RECELL® System

Market reaction Comment Full text

NLS Pharmaceutics Ltd. (NLSP)

  • Business News
  • Sept. 04, 2025, 11:38 UTC
  • 6
  • 0 comments

NLS Pharmaceutics and Kadimastem announce a Hong Kong Patent Covering Cell-Selection and Enrichment Technology for IsletRx for Diabetes Patients

Market reaction Comment Full text

Artelo Biosciences Inc. (ARTLW)

  • SEC News
  • Sept. 04, 2025, 11:37 UTC
  • 6
  • 0 comments

New Form 424B5 - ARTELO BIOSCIENCES, INC. Filed: 2025-09-04 AccNo: 0001640334-25-001624 Size: 560 KB

Comment Full text

XORTX Therapeutics Inc (XRTX)

  • SEC News
  • Sept. 04, 2025, 11:36 UTC
  • 4
  • 0 comments

New Form 6-K - XORTX Therapeutics Inc. Filed: 2025-09-04 AccNo: 0001171843-25-005726 Size: 12 KB

Comment Full text

Soligenix Inc. (SNGX)

  • Business News
  • Sept. 04, 2025, 11:33 UTC
  • 5
  • 0 comments

Soligenix Announces Publication Describing Long-Term High Temperature Stability of Protein Subunit Vaccines for Ebola and Related Viruses

Market reaction Comment Full text

Cybin Inc (CYBN)

  • Business News
  • Sept. 04, 2025, 11:30 UTC
  • 5
  • 0 comments

Cybin - Cybin to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

Market reaction Comment Full text

Nuvectis Pharma Inc (NVCT)

  • Business News
  • Sept. 04, 2025, 11:30 UTC
  • 4
  • 0 comments

Nuvectis Pharma to Participate at the H.C. Wainwright 27th Annual Global Investment Conference

Market reaction Comment Full text

Cybin Inc (CYBN)

  • Business News
  • Sept. 04, 2025, 11:30 UTC
  • 4
  • 0 comments

Cybin to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

Market reaction Comment Full text

Zevra Therapeutics, Inc. (ZVRA)

  • Business News
  • Sept. 04, 2025, 11:30 UTC
  • 4
  • 0 comments

Zevra Therapeutics Presents Positive New Data Supporting Foundational Role of MIPLYFFA® (arimoclomol) for the Treatment of Niemann-Pick Disease Type C at the International Congress of Inborn Errors of Metabolism (ICIEM)

Market reaction Comment Full text
  • Previous
  • 243
  • 244
  • 245
  • 246
  • 247
  • Next

Search

News categories

  • Technical Exchange News(10076)
  • Event(415)
  • SEC News(170479)
  • FDA Approval(9464)
  • Company Report(721)
  • Business News(113550)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin